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Curcumin potentiates the function of human α7-nicotinic acetylcholine receptors expressed 
in SH-EP1 cells. 
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Abstract 
Effects of curcumin, a biologically active ingredient of turmeric, were tested on the Ca2+ transients 
induced by the activation of α7 subunit of the human nicotinic acetylcholine (α7 nACh) receptor 
expressed in SH-EP1 cells. Curcumin caused a significant potentiation of choline (1 mM)-induced 
Ca2+ transients with an EC50 value of 133 nM. The potentiating effect of curcumin was not 
observed in Ca2+ transients induced by high K+ (60 mM) containing solutions or activation of α4β2 
nACh receptors and the extent of curcumin potentiation was not altered in the presence of Ca2+ 
channel antagonists nifedipine (1 µM), verapamil (1 µM), ω-conotoxin (1 µM), and bepridil (10 
µM). Noticeably the effect of curcumin was not observed when curcumin and choline were 
co-applied without curcumin pre-incubation.  The effect of curcumin on choline-induced Ca2+ 
transients was not reversed by pre-incubation with inhibitors of protein C, A, and CaM kinases. 
Metabolites of curcumin such as tetrahydrocurcumin, demethylcurcumin, and 
didemethylcurcumin also caused potentiation of choline-induced Ca2+ transients. Notably, specific 
binding of [125I]-bungarotoxin was not altered in the presence of curcumin. Collectively, our 
results indicate that curcumin allosterically potentiate the function of the α7-nACh receptor 
expressed in SH-EP1 cells.  
 
Keywords: Nicotinic receptors; curcumin; intracellular calcium; choline  
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1. Introduction 
Curcumin, a poly phenolic compound isolated from turmeric, has been demonstrated  to 
have various pharmacological activities ranging from anti-inflammatory, anti-cancer, anti-oxidant 
effects to anti-atherosclerotic, anti-microbial, and wound healing actions (Kunnumakkara et al., 
2016). Importantly, in recent years, curcumin has been shown to have beneficial effects in 
alleviating cognitive deficits in neurodegenereative disorders such as Alzheimer’s and Parkinson’s 
diseases (Ji and Shen, 2014; Goozee et al., 2016; Kunnumakkara et al., 2016). Although 
therapeutic effects of curcumin on several pathological conditions and animal disease models have 
been well documented, the molecular mechanism of curcumin effects in cells are poorly 
understood. 
These diverse pharmacological activities of curcumin are based on its chemical features 
and complex molecular structure, as well as its ability to interact with multiple signaling molecules 
(Zhang et al., 2014). To date, several membrane proteins including protein kinases, enzymes, 
transporters and ion channels have been identified as targets of curcumin (Zhang et al., 2014; 
Kunnumakkara et al., 2016).  
Nicotinic acetylcholine (nACh) receptors are important members of the ligand-gated ion 
channel family that includes GABAA, glycine, and 5-HT3 receptors. The homomeric α7 nACh 
receptor subtype is abundantly expressed in the central nervous system and periphery and plays a 
key role in synaptic plasticity and disease (Albuquerque et al., 2009). Neuronal α7-nACh receptors 
are recognized targets for drug development in several pre-clinical models of neuro-degenerative 
disorders including Alzheimer’s disease (Thomsen et al., 2010). In the present study, we have 
investigated the effects of curcumin on human α7-nACh receptors expressed in SH-EP1 cells. We 
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provide novel evidence that curcumin potentiates intracellular Ca2+ transients of the ligand-gated 
α7-nACh receptors. 
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2. Materials and Methods 
2.1. SH-EP1 cell culture: The SH-EP1 cells stably expressing the human α7 nAChR were a gift 
from Dr. R Lukas (Barrow Neurological Institute, Phoenix, AZ). Culturing of SH-EP1 cells was 
described earlier (Spivak et al., 2007, Sultan et al., 2017). Briefly, cells were grown on 35-mm 
dishes in Dulbecco’s modified Eagle’s medium (Invitrogen, Carlsbad, CA, USA) supplemented 
with 10% heat inactivated horse serum, 5% fetal bovine serum, 1 mM sodium pyruvate, 100 U/ml 
penicillin G, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, 0.4 mg/ml hygromycin B, and 
0.25 mg/ml Zeocin (all from Invitrogen). For measurements of intracellular [Ca2+], cells were 
plated at a density of 2x105 cells per well into 96-well plates and were kept for 2-3 days at 37 °C in 
an atmosphere of 5% CO2 saturated with H2O. Experiments were performed at room temperature 
(24 ± 2 °C).  
2.2. Measurement of intracellular [Ca2+]:  
The SH-EP1 cells were loaded with Krebs-HEPES (in mM: 144 NaCl, 5.9 KCl, 1.2 MgCl2, 2 
CaCl2, 11 D-glucose, 10 HEPES, pH 7.4) containing 10 µM fluo-4 AM (Molecular Probes, Life 
Technologies, Paisley, UK) for 45 min at 37 °C in the dark. After this incubation period, cells were 
washed twice with Krebs-HEPES at room temperature in the dark. Atropine (1µM) was included 
in all test and incubation solutions. Changes in fluorescence (excitation 485 nm, emission 520 nm) 
were measured using a fluorescent plate reader (Fluostar, BMG Labtech Inc., Cary, NC, USA). 
Basal levels of fluorescence were monitored before adding stimulation solution (1 mM choline or 
100 µM ACh) by using an automatic dispenser. After stimulation, changes in fluorescence were 
measured for 30 sec. To normalize fluo-4 signals, responses from each well were calibrated by 
measuring maximum and minimum fluorescence values. At the end of each experiment, addition 
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of 75 µl of 5% Triton X-100 (Fmax) was followed by addition of 50 µl of 1 M MnCl2 (Fmin). Data 
were calculated as a percentage of Fmax - Fmin and presented as % of Fmax - Fmin or area under 
fluorescence curve (AUC). Go-6983, KT-5720, KN-62; nifedipine, verapamil, bepridil, 
ω-conotoxin MVIIC, and α-bungarotoxin were purchased from Tocris (Tocris- Bio-Techne, 
Minneapolis, MN). Curcumin metabolites were purchased from Sigma (Sigma, St. Louis, MO). 
2.3. Radioligand binding experiments: 
The SH-EP1 cells grown to confluence in 35-mm dishes were collected by scraping in 50 mM 
HEPES buffer, pH 7.4, containing 1 mM MgCl2, 2.5 mM CaCl2, 0.1% (w/v) bovine serum albumin, 
0.025% (w/v) bacitracin and 0.025% (w/v) sodium azide. Subsequently, cells were centrifuged at 
1200 r.p.m. for 15 min at 4 ○C. After removal of the supernatant, the cells were frozen at -80 ○C 
until the day of the experiment. For each binding assay experiment, the cells were resuspended in 
50 mM Tris-HCl buffer (pH 7.4) containing 120 mM NaCl, 5 mM EDTA, 1.5 mM MgCl2 and 5 
mM KCl, using a Polytron tissue homogenizer at setting 4 for 20 s. Cell suspension (150 µl) was 
added to 96-well microtitre plates containing 50 µl radioligand [125I]-α-bungarotoxin (2200 
Ci/mmol; Perkin-Elmer, Inc. Waltham, MA, USA) and 50 µl test compound. Non-specific binding 
was determined in the presence of 3 µM α-bungarotoxin. The plates were incubated at room 
temperature for 45 min, rapidly filtered through Packard Unifilter-96, GF/C plates and washed 
twice with 500 µl ice-cold 10 mM Tris-HCl buffer containing 150 mM NaCl, pH 7.4. Filter-bound 
radioactivity was counted in 50 µl MicroScint 40 (Perkin-Elmer, Inc. Waltham, MA, USA) in 
Packard TopCount scintillation counter. Assays were performed in triplicate. 
2.4. Statistical analysis:  
Data were calculated as the mean ± standard error means (S.E.M.). One way ANOVA was 
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conducted to determine statistical significance between measurements in different groups. When 
differences existed, pair-wise post-hoc comparisons using the Bonferroni correction were 
completed. The P values < 0.05 were considered significant. Concentration-response curves were 
obtained by fitting the data to the logistic equation, 
           y = Emax/(1+[x/EC50]-n), 
where x and y are concentration and response, respectively, Emax is the maximal response, EC50 is 
the half-maximal concentration, and n is the slope factor (apparent Hill coefficient). 
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3. Results 
We examined the effects of curcumin in Fluo-4 loaded SH-EP1 cells stably transfected with 
human α7-nACh receptor. Application of curcumin alone in the concentrations up to 100 µM for 
30 sec. did not induce any detectable change in intracellular Ca2+ levels in (n=14 from 3 separate 
experiments). Application of choline (1 mM), a selective agonist for α7-nACh receptor 
(Albuquerque et al., 2009) for 30 sec. induced a rapid increase in intracellular Ca2+ concentrations 
(Fig. 1A, control). Application of non-selective cholinergic agonist, ACh was also found to 
produce a similar rise in intracellular Ca2+ (n=12; data not shown). Calcium transients induced by 
choline was completely inhibited by 10 min pre-incubation with 10 µM methyllycaconitine, a 
selective antagonist for α7-nACh receptor (Figs 1A and 1B). 
Pre-incubation with 1 µM curcumin (for 10 min) was associated with a significant 
potentiation (2.2 fold, n=12, ANOVA, P=0.001) of the choline-induced Ca2+ transient in the cells 
(Figs 1A and 1B). The effects of curcumin were concentration-dependent showing an IC50 value of 
133 nM (Fig. 1C). Notably, 10 min. applications of 10 µM curcumin, did not alter the magnitudes 
of Ca2+ transients induced by the application of high-K+ in the bath (60 mM KCl, n=14, ANOVA, 
P=0.579) or Ca2+ transients induced by 200 µM ACh in Fluo-4 AM loaded SH-EP1 cells 
expressing human α4β2-nACh receptor (n=14; ANOVA, P=0.078; Fig 1D). 
Entrance of Ca2+ through endogenously expressed voltage-gated Ca2+ channels in SH-EP1 
cells can contribute to Ca2+ transients induced by choline. Therefore, we have tested effects of 
curcumin in the presence of L-type Ca2+ channel antagonists nifedipine (1 µM) and verapamil (1 
µM), N-type Ca2+ channel antagonist ω-conotoxin MVIIC (1 µM), and nonselective Ca2+ channel 
antagonist, bepridil (10 µM). In the presence of these antagonists (n=15, P=0.068 for nifedipine 
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and n=19, P=0.086 for verapamil; n=11, P=0.074 for ω-conotoxin and n=14, P=0.083 for bepridil) 
curcumin (10 µM) continued to potentiate choline-induced Ca2+ transients (Figure 2A, and 2B). In 
the concentrations used in this study, these Ca2+ channel antagonists themselves did not have any 
effect on choline-induced Ca2+ transients (n=11-14, ANOVA, P>0.05). 
Co-application of curcumin and choline, without pre-incubation with curcumin, was not 
associated with a rise in the choline-induced Ca2+ transients (n=18, ANOVA, P=0.512) suggesting 
that the effects of curcumin on nACh receptor Ca2+ signal require receptor priming by additional 
cellular mechanisms such as kinases. We therefore investigated the involvement of protein kinases 
A, C, and Ca2+-calmodulin dependent kinase (CaM-kinase), which are known to regulate functions 
of ligand-gated ion channels (Zhang et al., 1995; Talwar and Lynch, 2014), in curcumin’s effect on 
α7-nACh receptor Ca2+ response. A 30 min. pretreatment with 3 µM Go-6983 (Go; protein kinase 
C specific inhibitor; Young et al., 2005), 10 µM KT-5720 (KT; protein kinase A specific inhibitor; 
Cabell and Audesirk, 1993), or 10 µM KN-62 (KN; CaM kinase II specific inhibitor, Tokumitsu et 
al., 1990) was found to have no effect on curcumin (10 µM) mediated potentiation of the choline 
(1 mM)-induced Ca2+ response (ANOVA; n=18-21; P=0.001 for Go, KT, and KN groups). The 
results of these experiments were presented in Figure 3A. After 30 min. pretreatment, protein 
kinase inhibitors (Go, KT, KN) at the concentrations used in this study did not cause any alterations 
on the choline-induced Ca2+ transients (n=12-14). 
In vivo curcumin is known to be metabolized to compounds such as tetrahydrocurcumin 
(THC), demethylcurcumin (DMC), and didemethylcurcumin (DDMC) (Anand et al., 2007). We 
tested the effects of these curcumin metabolites on choline-induced Ca2+ transients in SH-EP1 
cells. Our findings indicate that these curcumin metabolites (at 10 µM concentrations) can also 
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significantly (ANOVA; n=12-16; P=0.001 for THC, DMC, and DDMC groups) potentiate 
choline-induced Ca2+ transients in this cell line (Fig 3B).   
[125I] α-bungarotoxin competes with ACh, an endogenous activator of α7-nACh receptors 
by binding to the ACh binding site on the receptor (Albuquerque et al., 2009). For this reason, the 
effect of curcumin was investigated on the specific binding of [125I] α-bungarotoxin. Saturation 
curves for the binding of [125I] α-bungarotoxin, in the presence and absence (controls) of curcumin 
are presented in Fig. 4A. At a concentration of 10 µM, curcumin did not cause a significant 
alteration in the specific binding of [125I] α-bungarotoxin. The apparent affinity (KD) of the receptor 
for [125I] α-bungarotoxin was 0.71 ± 0.16 and 0.76 ± 0.21 pM for controls and curcumin, 
respectively (n= 9 measurement from 3 experiments; ANOVA, P=0.089). Further analysis of 
saturation binding data by Scatchard analysis (Fig 4B) indicated that, in the absence and presence 
of curcumin (10 µM), there is no significant alteration in a Bmax values. In the absence and presence 
of curcumin, Bmax values were  0.746 ± 0.065 pmol/mg and 0.781 ± 0.087 pmol/mg, respectively 
(n= 9 measurement from 3 experiments, ANOVA, P=0.073).  
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4. Discussion 
In the present study, we provide novel evidence that curcumin potentiates the function of 
human α7-nACh receptors expressed in SH-EP1 cells. Potentiation by curcumin occurs in a time 
and concentration dependent manner, but appears independent of channel phosphorylation by 
protein A, C, and CaM type kinases. The findings underscore a role for curcumin in the regulation 
of α7-nACh receptor signaling in various cells. 
Our findings suggest that the application of curcumin alone is not sufficient to promote a 
detectable change in intracellular Ca2+ within cells. However, 10 min. pre-incubation with 
curcumin can significantly potentiate the Ca2+ transients response of the ligand activated α7-nACh 
receptors suggesting that curcumin functions as a positive modulator of α7-nACh receptors. Since, 
Ca2+ transients induced by high K+ containing solutions and activation of α4β2 nACh receptors 
were not altered by pre-incubation with 10 µM curcumin, the effects of curcumin appear specific 
to α7-nACh receptors. 
Interestingly, these functional effects of curcumin appeared dependent on its application 
prior to the receptor ligand as evidenced by our finding that co-application of curcumin and choline 
does not alter the choline-induced Ca2+ transients. Although the kinetics of curcumin effect were 
not studied in detail in this report, our comparison of the effect of curcumin application (before and 
during) choline stimulation of the receptor indicates that the potentiating effects of curcumin are 
achieved after several seconds of ligand preexposure. This time dependent effect of curcumin on 
the choline response of the nACh receptor suggests that additional cellular pathways upstream of 
the receptor are engaged by curcumin in these cells. However, inhibition of key nACh receptor 
modulating kinases such as protein kinase A, C, and CaM by specific inhibitors did not reverse the 
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effect of curcumin suggesting that phosphorylation by the kinases is not required for curcumin’s 
effects on the nACh receptor. In the future studies, it will be important to test the effects of 
curcumin on other pathways including those pathways that have been demonstrated to be activated 
by curcumin such as several integral membrane proteins including enzymes, transporters, and ion 
channels (Zhang et al., 2014).  
Notably, the results of radioligand binding experiments indicate that curcumin does alter 
specific binding of [125I] α-bungarotoxin suggesting that curcumin may act as allosteric modulator 
of α7-nACh receptor. In this study, curcumin was applied in the concentration range of 10 nM to 
10 µM and was found that it can enhance the function of α7-nACh receptors in a 
concentration-dependent manner with EC50 value of 231 nM. Interestingly, even the major 
metabolites of curcumin tetrahydrocurcumin, demethylcurcumin, and didemethylcurcumin 
(Anand et al., 2007) can also potentiate the choline-induced Ca2+ transients, suggesting bioactivity 
of these curcumin metabolites at the α7-nACh receptor site. The concentration of curcumin in 
plasma and its ability to pass the blood brain barrier following oral and intravenous administration 
has been studied previously (Shoba et al., 1998; Anand et al., 2007). When curcumin is given 
orally at a dose of 2 g/kg to rats, maximum serum concentration of 1.35 µg/ml (3.5 µM) was 
attained (Shoba et al., 1998). Since curcumin is a highly lipophilic compound with LogP 
(octanol–water partition coefficient) value of 3.3, its membrane concentration is expected to be 
considerably higher than blood levels. Therefore, the functional modulation of α7-nACh receptors 
demonstrated in this study can be pharmacologically relevant. 
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FIGURE LEGENDS 
Figure 1. The effects of curcumin on intracellular Ca2+ transients induced by activation of the 
human α7 nACh receptors expressed in SH-EP1 cells. (A) The effect of curcumin (1 µM) and 
methyllycaconitine (MLA, 10 µM), a selective antagonist for α7-nACh receptor, on choline (1 
mM)-induced intracellular Ca2+ transients in SH-EP1 cells loaded with 10 µM Fluo-4 AM. (B) 
Summary of the effects of curcumin and MLA on the area under choline-induced Ca2+ transients. 
Bars represent the mean± S.E.M. n=18-21. (C) Concentration-inhibition curve for the effect of 
curcumin on the area under choline (1 mM)-induced Ca2+ transients. Each data point presents the 
normalized means and S.E.M. n=12-16. The curve is the best fit of the data to the logistic equation 
described in the methods section. (D) The effect of curcumin on the area under Ca2+ transients 
elicited by the activation (200 µM ACh) of α4β2 nACh.receptors and by the application of high K+ 
(60 mM) in SH-EP1 cells. Bars represent the mean % potentiation ± S.E.M. n=14. 
 
Figure 2. The effects of Ca2+ channel inhibitors on choline-induced Ca2+ transients in SH-EP1 
cells expressing α7-nACh receptor. (A) The effect of L-type Ca2+ channel antagonists nifedipine 
and verapamil on curcumin (10 µM) potentiation of choline-induced Ca2+ transients in SH-EP1 
cells expressing α7-nACh receptor. SH-EP1 cells were pre-incubated for 10 min with nifedipine (1 
µM), and verapamil (1 µM). Control included 10 µM curcumin and the vehicle (0.01% DMSO). 
Bars represent the mean % potentiation ± S.E.M. n=15-19. (B) The effects of ω-conotoxin and 
bepridil on curcumin (10 µM) potentiation of choline-induced Ca2+ transients in SH-EP1 cells 
expressing α7-nACh receptor. SH-EP1 cells were pre-incubated for 10 min with ω-conotoxin (1 
µM), and bepridil (10 µM). Control included 10 µM curcumin and the vehicle (0.01% DMSO). 
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Bars represent the mean % potentiation ± S.E.M. n=11-14. 
 
Figure 3. The effects of protein kinase inhibitors and curcumin metabolites on choline-induced 
Ca2+ transients in SH-EP1 cells expressing α7-nACh receptor. (A) The effect of protein kinase 
inhibitors on curcumin (10 µM) potentiation of choline-induced Ca2+ transients in SH-EP1 cells 
expressing α7-nACh receptor. SH-EP1 cells were pre-incubated for 30 min with Go-6983 (specific 
protein kinase C inhibitor, Go; 3 µM), KT-5720 (specific protein kinase A inhibitor, KT; 3 µM), 
and KN-62 (specific inhibitor of CaM kinase II, KN; 10 µM). Bars represent the mean % 
potentiation ± S.E.M. n=18-21. (B) The effects of curcumin metabolites on choline-induced Ca2+ 
transients in SH-EP1 cells expressing α7-nACh receptor. SH-EP1 cells were pre-incubated with 10 
µM of curcumin metabolites including tetrahydrocurcumin (THC), demethylcurcumin (DMC), 
and didemethylcurcumin (DDMC) for 30 min. Bars represent the mean % potentiation ± S.E.M. 
n=12-16. 
Figure 4.  The effect of curcumin on the specific binding of [125I] α-bungarotoxin in SH-EP1 cells. 
(A) The effect of curcumin on the saturation curves for [125I] α-bungarotoxin binding. [125I] 
α-bungarotoxin concentrations represent free ligand. Membranes from SH-EP1 cells was 
incubated with the indicated concentrations of [3H]-nicotine for 45 min in the absence (filled 
circles) and presence (open circles) of curcumin (10 µM) at room temperature. Non-specific 
binding was determined by the inclusion of unlabeled bungarotoxin (3 µM) in the incubation 
buffer. Data are from a single experiment. (B): Scatchard analysis of the effects of curcumin on 
saturation binding of [125I] α-bungarotoxin. Units for x and y axis are fmol/mg protein and 
fmol/mg protein/nM, respectively.  
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• Curcumin potentiated Ca2+ transients induced by the activation of α7 nACh 
receptor in SH-EP1 cells.  
• Effect of curcumin was not reversed by pre-incubation of inhibitors of protein C, 
A, and CaM kinases. 
• Metabolites of curcumin caused potentiation of choline-induced Ca2+ transients. 
• Specific binding of [125I]-bungarotoxin was not altered in the presence of 
curcumin 
 
